The DAVID (Dual Chamber and VVI Implantable Defibrillator) II Trial

Journal of the American College of Cardiology

Volumn 53, Issue 10, 2009, Pages 872-880

  Wilkoff, Bruce L ^a   Kudenchuk, Peter J ^b   Buxton, Alfred E ^c   Sharma, Arjun ^d   Cook, James R ^e   Bhandari, Anil K ^f   Biehl, Michael ^g   Tomassoni, Gery ^h   Leonen, Anna ^b   Klevan, Linette R ⁱ   Hallstrom, Alfred P ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BROWN UNIVERSITY   (United States)

^d Medtronic Cardiac Rhythm Management   (United States)

^e BAYSTATE MEDICAL CENTER   (United States)

^f GOOD SAMARITAN HOSPITAL   (United States)

^g ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

^h CENTRAL BAPTIST HOSPITAL   (United States)

ⁱ SENTARA NORFOLK GENERAL HOSPITAL   (United States)

Author keywords

heart failure; implantable defibrillator; pacing

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART FAILURE; HEART VENTRICLE FAILURE; HEART VENTRICLE PACING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYNCOPE; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; CARDIOVASCULAR AGENTS; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTHESIS DESIGN; QUALITY OF LIFE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 60949106339     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.10.057     Document Type: Article

References (20)

1. DAVID Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. JAMA 288 (2002) 3115-3123
2. Tops L.F., Suffoletto M.S., Bleeker G.B., et al. Speckle-tracking radial strain reveals left ventricular dyssynchrony in patients with permanent right ventricular pacing. J Am Coll Cardiol 50 (2007) 1180-1188
3. Cha Y.M., Nishimura R.A., and Hayes D.L. Difference in mechanical atrioventricular delay between atrial sensing and atrial pacing modes in patients with hypertrophic and dilated cardiomyopathy. J Interv Card Electrophysiol 6 (2002) 133-140
4. Kutalek S.P., Sharma A.D., McWilliams M.J., et al. Effect of pacing for soft indications on mortality and heart failure in the Dual Chamber and VVI Implantable Defibrillator (DAVID) trial. Pacing Clin Electrophysiol 31 (2008) 828-837
5. Heart Failure Society of America (HFSA) Practice Guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction. J Card Fail 5 (1999) 357-382
6. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-Item Short-Form Health Survey (SF-36). Med Care 30 (1992) 4730-4783
7. In: Ware J.E., Snow K.K., Kosinski M., and Gandek B. (Eds). SF-36 Health Survey (1993), Health Institute, New England Medical Center, Boston, MA
8. Lamas G.A., Oray J.E., Stambler B.S., et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual chamber pacing. N Engl J Med 338 (1998) 1097-1104
9. Rector T.S., Kubo S.H., and Cohn J.N. Patients self-assessment of their congestive heart failure: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Failure 3 (1987) 198-209
10. Kubo S.H., Gollub S., Bourge R., et al. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Circulation 85 (1992) 942-949
11. Lindley R.I., Waddell F., Livingstone M., et al. Can simple questions assess outcome after stroke?. Cerebrovasc Dis 4 (1994) 314-324
12. East 2000-Software for the Design and Interim Monitoring of Group Sequential Clinical Trials User Manual (2001), Cytel Software Corp, Cambridge, MA
13. Andersen H.R., Nielsen J.C., Thomsen P.E., et al. Long term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet 350 (1997) 1210-1216
14. Adelstein E., and Saba S. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients. Am Heart J 155 (2008) 94-99
15. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
16. Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 (1999) 1882-1890
17. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
18. Sharma A.D., Rizzo-Patron C., Hallstrom A.P., et al. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2 (2005) 830-834
19. Steinberg J.S., Fischer A., Wang P., et al. The clinical implications of cumulative right ventricular pacing in the Multicenter Automatic Defibrillator Trial II. J Cardiovasc Electrophysiol 16 (2005) 359-365
20. Olshansky B., Day J.D., Moore S., et al. Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator. Circulation 115 (2007) 9-16